1.Clinical application of peritoneal dialysis in the treatment of heart failure patients with diuretic resistance
Shuiqin CHENG ; Le YU ; Zhihong ZHANG ; Yusheng YU
Chinese Journal of Nephrology 2024;40(7):573-577
There are numerous novel therapies available for heart failure (HF) nowadays, but the condition of HF patients with diuretic resistance is notably complicated and severe, and its treatment is challenging. The main mechanisms of diuretic resistance in HF patients were the decrease of body's response to diuretics due to various reasons, and the retention of water and sodium. Peritoneal dialysis stands out as a safe and effective choice for the treatment of diuretic resistance in HF patients because of its advantages of ultrafiltration, sodium excretion, improvement of cardiac function, and preservation of residual renal function. This review outlines the rationale and clinical application of peritoneal dialysis in treating HF patients with diuretic resistance, to provide clinical guidance.
2.Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens.
Tao LIU ; Yachen TIAN ; Cheng LIU ; Shuiqin FANG ; Youxue WU ; Meijiao WU ; Bin LI ; Hao YANG ; Qing LIU
Chinese Journal of Biotechnology 2021;37(11):3890-3904
Clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeats -associated protein (CRISPR/Cas) has been developed as a precise, efficient, affordable and sensitive nucleic acid detection tool due to its efficient targeted binding ability and programmability. At present, biosensors based on CRISPR-Cas system have shown excellent performance in the detection of nucleic acid of pathogens, which has attracted widespread attention, and is expected to replace the conventional detection methods. This review summarizes the latest research progress of biosensors based on CRISPR/Cas system for detecting nucleic acid of pathogens.
Biosensing Techniques
;
CRISPR-Cas Systems/genetics*
;
Nucleic Acids/genetics*
3.Research progress in the rapid preparation of monoclonal antibodies of mouse hybridoma.
Shuiqin FANG ; Cheng LIU ; Junfei MA ; Shuaishuai YAN ; Dongpo XU ; Qing LIU
Chinese Journal of Biotechnology 2021;37(7):2293-2306
Mouse hybridoma monoclonal antibody is the most commonly used antibody in immunology because of its stable source, easy preparation in later stage and high yield. The traditional time-consuming and laborious hybridoma preparation technology could not meet the growing market demand. In this paper, we describe the rapid preparation techniques involved in antigen design and screening, B cell enrichment and screening, transgenic myeloma cells, fusion technology improvement, positive hybridoma cell screening and rapid detection of monoclonal antibody performance, to provide a reference for rapid preparation of mouse hybridoma monoclonal antibody.
Animals
;
Antibodies, Monoclonal
;
Antigens
;
B-Lymphocytes
;
Hybridomas
;
Mice

Result Analysis
Print
Save
E-mail